In conclusion, chemerin can promote NF-κB activation through inhibiting of SIRT1 activity by ROS production and consequently induce an inflammatory response, leading to the development of obesity and psoriasis. The gene discussed is RARRES2; the disease is obesity due to melanocortin 4 receptor deficiency.